Search results
6 Things To Do Now If You Have More Than $5,000 in Your Checking Account
GoBankingRates via AOL· 5 days agoA recent GOBankingRates survey shows that 9 out of 10 people possess checking accounts. But despite...
My husband and I are semi-retired. We want to maintain our lifestyle until we’re hopefully 100 — yet...
Market Watch· 7 days agoAnswer: This certainly sounds like a challenge that a financial planner could help you with — and...
Procore Technologies director Kevin O'Connor sells over $1m in stock By Investing.com
Investing.com· 7 hours agoProcore Technologies , Inc. (NYSE:PCOR) Director Kevin J. O'Connor has sold a significant number of...
Italy's bad loan manager doValue to buy rival Gardant, shares surge
Reuters· 7 days ago, opens new tab has agreed to buy rival Gardant in a cash-and-stock deal, the country's biggest bad loan company said early on Friday, bulking up in the face of ebbing flow ...
Best CD rates today: Follow leading APYs to guaranteed returns on terms of 12+ months — June 11,...
AOL· 3 days agoTypical CD rates are fixed, which means you're guaranteed a rate of return that doesn't change....
Monster Beverage’s chairman and co-CEO sells over $21m in stock By Investing.com
Investing.com· 8 hours agoMonster Beverage Corp (NASDAQ:MNST) has reported a significant transaction by Chairman and Co-CEO...
Monster Beverage director sells over $781k in company stock By Investing.com
Investing.com· 8 hours agoMonster Beverage Corp (NASDAQ:MNST) director Mark Vidergauz has sold a total of 15,077 shares of the...
Zacks Industry Outlook NMI Holdings, HCI, and Skyward Specialty
Zacks via Yahoo Finance· 4 days agoThe industry has been witnessing improving pricing, albeit at a slower pace. ... P&C insurers’...
I’m a Banker: 4 Saving Strategies I Swear By for Long-Term Wealth
GoBankingRates via AOL· 3 days agoWhen it comes to saving money, there's no one-size-fits-all strategy. What might work for some...
BioRestorative Therapies maintains its 'Buy' rating and $15 target price By Investing.com
Investing.com· 2 days ago(NASDAQ:BRTX) maintained its Buy rating and a price target of $15.00, as confirmed by Roth/MKM. The...